| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 06/25/2002 | US6410245 Complexing; fusion proteins; quantitative analysis |
| 06/20/2002 | US20020076453 Angiotensin I-converting enzyme inhibitory substance |
| 06/13/2002 | WO2002045524A2 Prolyl endoprotease from aspergillus niger |
| 06/13/2002 | WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/13/2002 | CA2430893A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/06/2002 | WO2001079242A3 Process for preparing lipid ii and derivatives thereof |
| 06/06/2002 | US20020068301 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 05/29/2002 | CN1351174A Inhibiting material for inverting enzyme for angiotensin I |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/02/2002 | EP1201679A2 Angiotensin I-converting enzyme inhibitory substance |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/27/2002 | CA2360015A1 Angiotensin i-converting enzyme inhibitory substance |
| 04/11/2002 | WO2002012275A3 Lat peptides and their use in assays for identifying immunosuppressants |
| 04/11/2002 | US20020042381 Antilipemic agents |
| 03/28/2002 | US20020037326 Peptides for inhibiting retroviruses |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/19/2002 | US6359112 Peptides used as agonists and/or inhibitors of amyloid formation and cytotoxicity and also for use in alzheimer's disease, in type II diabetes mellitus and in spongiform encephalophathies |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 02/26/2002 | US6350572 Interaction between cyclin D1 and steroid receptor coactivators and users thereof in assays |
| 02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/05/2002 | CA2116066C Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays |
| 02/05/2002 | CA2098113C Substances of polypeptide nature useful in human therapy |
| 01/23/2002 | EP1173600A2 Cationic peg-lipids and methods of use |
| 12/25/2001 | US6333305 For therapy of fungal infections |
| 12/25/2001 | CA2139385C Products containing g-csf and tnf binding protein |
| 12/05/2001 | EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
| 11/07/2001 | CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use |
| 10/25/2001 | WO2001079242A2 Process for preparing lipid ii and derivatives thereof |
| 10/25/2001 | CA2406952A1 Process for preparing lipid ii |
| 10/24/2001 | EP1147130A1 Alpha-conotoxin peptides |
| 10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
| 10/17/2001 | CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof |
| 10/02/2001 | US6297216 Administering a dipeptide derivative to mammals |
| 09/25/2001 | CA2110058C Hepatitis c virus (hcv) polypeptides |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6287761 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/16/2001 | WO1999064046A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 08/09/2001 | WO2000062813A3 Cationic peg-lipids and methods of use |
| 08/02/2001 | CA2366828A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117645A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6261548 Polypeptides for leukemia inhibitor factors with amino acid sequences |
| 07/05/2001 | US20010007015 Can be used as the basic structures (template molecules) for inhibiting and analysing amyloid formation and cytotoxicity in amyloid illnesses |
| 07/04/2001 | CN1302211A Improvements in/or relating to diagnostic/therapeutic agent |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105149A1 Methods to increase blood flow to ischemic tissue |
| 06/12/2001 | US6245744 Antilipemic agents |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/09/2001 | EP1097165A1 Novel inhibitors of angiogenesis and tumor growth |
| 05/09/2001 | CN1065538C Antibiotic stalobacins |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/18/2001 | CN1291992A Isolated, polypeptides which bind to HLA-A29 molecules, nucleic acid, molecules encoding there, and uses thereof |
| 04/18/2001 | CN1291991A Novel peptide having biological activity |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085888A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083918A1 Novel therapeutic agents that modulate 5-ht receptors |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |